A method of printing a hydrogel scaffold is provided which includes providing a container containing an ink and a liquid that is immiscible with the ink; applying light from a light source to the ink to form a portion of the hydrogel scaffold; and from a light source one or more additional times to produce one or more additional portions of the hydrogel scaffold.

The invention comprises a peelable membrane for resealably closing a metal end comprising an outer layer, a tacky layer, and a heat seal layer. The heat seal layer is permanently sealed to the metal end to cover at least one opening in the metal end. The tacky layer causes the peelable membrane to be resealable onto the metal end.

A liquid crystal polyester resin comprising 42 to 80 mol % of structural unit (I) relative to 100 mol % of the total structural unit of the liquid crystal polyester resin, and ΔS (entropy of melting) defined by equation [1] is 0.01×10.sup.−3 to 2.7×10.sup.−3 J/g.Math.K:

ΔS(J/g.Math.K)=ΔHm(J/g)/Tm(K)  [1]

wherein Tm is an endothermic peak temperature determined by: after observation of an endothermic peak temperature (Tm.sub.1) observed when heating a liquid crystal polyester under temperature rising conditions of 20° C./minute from room temperature in differential scanning calorimetry, the liquid crystal polyester was maintained at a temperature of Tm.sub.1+20° C. for 5 minutes, followed by observation of the endothermic peak temperature observed when the temperature has fallen to room temperature under temperature falling conditions of 20° C./minute and then raised under temperature rising conditions of 20° C./minute, and ΔHm is an endothermic peak area of Tm:

##STR00001##

A film includes a copolymer having a tetrafluoroethylene-based unit and an ethylene-based unit, in which the film has a haze of from 1.2% to 8.0%, an ultraviolet reflectance of less than 17.0%, and a thickness of from 250 to 400 μm.

The instant application discloses, among other things, ways to manufacture reduced density thermoplastics. A rapid foaming process which may create a polymer product by saturating thermoplastic sheet or preforms, heating, and then forming into final shape, is described. The polymer product may include an integral solid skin. This method may be utilized with any thermoplastic. The material handling, saturation methods, and end products are also described.

The invention disclosed herein is an automotive acoustic panel including a porous sound-absorption material made from a polymer and an expanded perlite. One or more silane compounds may be coupled or coated onto the expanded perlite while a coupling agent and a chemical foaming agent may additionally be added to the automotive acoustic panel.

The present invention concerns a chemical mechanical polishing pad having a polishing layer. The polishing layer contains an extruded sheet. The extruded sheet is prepared by extruding a compounded photopolymerizable composition followed by exposure to UV light.

The present invention is directed at poly(ethylene terephthalate)-poly(ethylene naphthalate (PET-PEN) copolymer extruded sheet that is thermoformable and particularly suitable for medical device packaging, as well as medical device packaging made from such PET-PEN sheet material.

Modeling material formulations and formulation systems usable in additive manufacturing of a three-dimensional object, featuring, when hardened, a Shore A hardness lower than 10 and/or a Shore 00 hardness lower than 40, are provided. Additive manufacturing processes utilizing these formulations and formulation systems, and three-dimensional objects obtainable thereby, are also provided.

Non-invasive Ocular Drug Delivery Insert Technology. The invention concerns an ocular insert which is a new biocompatible polymer-based controlled drug delivery system (CDDS) applicable to a variety of drugs and other compounds for the treatment of different ocular pathologies. This ocular insert allows releasing of at least one drug under suitable concentration levels during suitable periods of time. The device may be inserted in the lower or upper fornix conjunctiva, in a non-invasive way, meaning that the patient will be able to place the device himself, without intervention of medical specialized staff. The insert of the invention will release the drug in such a controlled rate that will allow the drug release up to 300 days by either a “Fickian” or a linear profile according to the intend purpose or pathology. The insert can be prepared with different shapes (spherical or spherical dome) and/or architectures (monolithic/layered either with or without a drug core) allowing the incorporation of at least one drug which can be released at different rates. The size, shape and design of the insert is adjusted in order to tune the drug(s) delivery profile(s) and to inhibit the risk of displacement or expulsion.